BDBM3688 4-[(3-Bromophenyl)amino]-6-[[2-(4-morpholino)ethyl]-amino]pyrimido[5,4-d]pyrimidine::4-anilinopyrimido[5,4-d]pyrimidine deriv. 5g::8-N-(3-bromophenyl)-2-N-[2-(morpholin-4-yl)ethyl]-[1,3]diazino[5,4-d]pyrimidine-2,8-diamine

SMILES: Brc1cccc(Nc2ncnc3cnc(NCCN4CCOCC4)nc23)c1

InChI Key: InChIKey=FBSRQIPWINDALQ-UHFFFAOYSA-N

Data: 2 IC50

Find this compound or compounds like it in BindingDB or PDB:

Substructure Similarity at least:  must be >=0.5 Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 3688   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kcal/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
Epidermal growth factor receptor (Homo sapiens (Human))	BDBM3688 (4-[(3-Bromophenyl)amino]-6-[[2-(4-morpholino)ethyl...) Show SMILES Brc1cccc(Nc2ncnc3cnc(NCCN4CCOCC4)nc23)c1 Show InChI InChI=1S/C18H20BrN7O/c19-13-2-1-3-14(10-13)24-17-16-15(22-12-23-17)11-21-18(25-16)20-4-5-26-6-8-27-9-7-26/h1-3,10-12H,4-9H2,(H,20,21,25)(H,22,23,24)	PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Patents Similars	Article PubMed	n/a	n/a	0.813	n/a	n/a	n/a	n/a	n/a	n/a
University of Zurich Curated by ChEMBL					Assay Description Inhibition of EGFR				J Med Chem 51: 1179-88 (2008) Article DOI: 10.1021/jm070654j BindingDB Entry DOI: 10.7270/Q29Z95RD
					More data for this Ligand-Target Pair
Epidermal growth factor receptor (Homo sapiens (Human))	BDBM3688 (4-[(3-Bromophenyl)amino]-6-[[2-(4-morpholino)ethyl...) Show SMILES Brc1cccc(Nc2ncnc3cnc(NCCN4CCOCC4)nc23)c1 Show InChI InChI=1S/C18H20BrN7O/c19-13-2-1-3-14(10-13)24-17-16-15(22-12-23-17)11-21-18(25-16)20-4-5-26-6-8-27-9-7-26/h1-3,10-12H,4-9H2,(H,20,21,25)(H,22,23,24)	PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Patents Similars	Article PubMed	n/a	n/a	0.810	n/a	n/a	n/a	n/a	7.4	22
University of Auckland					Assay Description IC50 is the inhibitor concentration which inhibits 50% of kinase activity that catalyzes the transfer of the terminal phosphate from [gamma-32P] labe...				J Med Chem 40: 1820-6 (1997) Article DOI: 10.1021/jm960879m BindingDB Entry DOI: 10.7270/Q2J101C8
					More data for this Ligand-Target Pair